Lindus Health

Tech-enabled 'anti-CRO' running end-to-end clinical trials on its own integrated eClinical platform with fixed-price delivery.

Lindus Health, founded in 2021 and headquartered in London, United Kingdom, positions itself as an 'anti-CRO' — running end-to-end clinical trials on Citrus, its own integrated eClinical platform spanning EDC, ePRO, eConsent, and recruitment, with fixed-price, milestone-based contracts. The company raised a $55M Series B led by Balderton Capital in January 2025 and also operates a US office in New York. Atlas found no vendor-held security certifications documented on its site.

Headquarters
London, United Kingdom
Founded
2021
Deployment options
cloud
Website
https://www.lindushealth.com
LinkedIn
https://www.linkedin.com/company/lindushealth

Categories

AI Use Cases

  • Digital/Decentralized Trials
  • Patient Recruitment & Enrollment

Vendor Scorecard

50% — Partial coverage. Coverage score — how completely Atlas documents Lindus Health across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.

Compliance & Validation — Not documented by Atlas

Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?

Deployment & Hosting — Documented

cloud

Pricing Transparency — Not documented by Atlas

Ask the vendor: What is your pricing model, and what drives total cost of ownership?

Implementation & Onboarding — Not documented by Atlas

Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?

Organization & Role Fit — Documented

Biotech Startup, Mid-Size Biotech, Large Pharma, Clinical Operations, R&D Leadership

Solution Scope — Documented

Digital/Decentralized Trials, Patient Recruitment & Enrollment

Company Viability — Partially documented

Series B, Founded 2021

Always ask the vendor

Not captured in Atlas data — confirm directly. Excluded from the score above.

Data Rights & IP

Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?

Model Credibility & Explainability

Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?

Questions to Ask This Vendor

  • Which therapeutic areas and trial phases has the model been used for end to end?
  • How does the fixed-price contract handle protocol amendments and scope changes?
  • What validation and compliance documentation covers the Citrus platform?
  • How is data exported to sponsor systems at study close?